期刊文献+

源于菊科植物的畲药特点及研究现状分析 被引量:1

Analysis on Characteristics and Research Status of She Medicine from Compositae Plants
原文传递
导出
摘要 目的分析基原植物是菊科植物的畲药(以下简称“菊科畲药”)品种特点和研究现状,为菊科畲药的深度研究开发提供参考依据。方法通过对《中国民族药辞典》中菊科畲药的系统整理和相关文献检索,从药用部位、多民族交叉使用情况、传统功效、化学成分和药理活性研究进展、质量控制标准等多个角度,系统梳理了菊科畲药的品种特点和研究现状。结果菊科畲药是数量最多的一类畲药品种,其药用部位主要是全草类,与土家药的交叉使用最多,主要用于治疗皮肤瘙痒、疮疖、疔疖和烂脚等皮肤性疾病和外感性疾病,但是菊科畲药还存在基原植物不明确、化学成分和药理活性研究薄弱、质量控制标准水平较低等问题。结论菊科畲药具有较高的临床应用价值,但是其研究水平还是相对较低,后期还需进一步加强基原植物的品种整理、药效物质基础的分析以及体现畲药特点的质量控制标准构建等工作。 OBJECTIVE To provide a reference for the in-depth research and development of She medicine from Compositae plants(hereinafter referred to as“compositae She medicine”)by analyze its variety characteristics and research status.METHODS Through systematic review of Dictionary of Chinese Ethnic Medicine and related literature retrieval,the variety characteristics and research status of compositae She medicine were systematically combed from the perspectives of medicinal parts,multi-ethnic cross use,traditional efficacy,research progress of chemical composition and pharmacological activity,quality control standards,etc.RESULTS Compositae She medicine was the most numerous She medicine category,which mainly used whole herbs as medicinal parts and had the most cross-use with Tujia medicine.It was mainly used to treat skin diseases(such as skin pruritus,sore boils,malignant boil,rotten feet,etc.)and exogenous diseases.However,there were still remain some problems in compositae She medicine development,such as botanical origin ambiguity,insufficient studies on chemical composition and pharmacological activity and low-level standards of quality control.CONCLUSION Compositae She medicine has high clinical application value,whereas its research level is still relatively low.In future,the variety arrangement of botanical origin,analysis of therapeutic material basis,and construction of quality control standards reflecting the characteristics of She medicine should be further strengthened.
作者 林怡洁 朱虹 刘赛 陈旭波 童应鹏 程科军 LIN Yijie;ZHU Hong;LIU Sai;CHEN Xubo;TONG Yingpeng;CHENG Kejun(Institute of Natural Medicine and Health Product,School of Life Science,Taizhou University,Taizhou 318000,China;College of Ecology,Lishui University,Lishui 323000,China;Lishui Institute of Agriculture and Forestry Sciences,Lishui 323000,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2021年第19期2463-2467,共5页 Chinese Journal of Modern Applied Pharmacy
基金 国家重点研发计划中医药现代化研究重点专项项目(2017YFC1703903) 浙江省重大科技专项(2012C12014-1)。
关键词 菊科 畲药 特点 研究现状 Compositae plants She medicine characteristics research status
  • 相关文献

参考文献16

二级参考文献252

共引文献179

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部